Award
National Institute of Diabetes and Digestive and Kidney Diseases 5K01DK128128-05
Activation of C/EBP-β by mitohormesis as a therapy for obesity
Recipient
University of Washington, Seattle, WA, United States
Award Amount
$146,750.00
Ceiling
$146,750.00
Awarded
March 03, 2026
Identifier
5K01DK128128-05
The award supports research on activating the transcription factor C/EBP-β through mitohormesis to develop new therapies for obesity, focusing on energy expenditure and fat metabolism.
Description
This project explores the activation of C/EBP-β via mitohormesis as a potential therapeutic approach for obesity, integrating advanced techniques in energy metabolism and genetic models.